Chemical Structure : LX2761
Catalog No.: PC-60689Not For Human Use, Lab Use Only.
LX2761 is a potent, locally acting and orally bioavailable SGLT1 inhibitor that inhibits human SGLT1- and SGLT2-mediated glucose uptake with IC50 of 2.2 nM and 2.7 nM, respectively, restricted to the intestinal lumen.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LX2761 is a potent, locally acting and orally bioavailable SGLT1 inhibitor that inhibits human SGLT1- and SGLT2-mediated glucose uptake with IC50 of 2.2 nM and 2.7 nM, respectively, restricted to the intestinal lumen.
LX2761 synergistically increases active GLP-1 levels combined with sitagliptin, lowers postprandial glucose, fasting glucose, and hemoglobin A1C, and increased plasma total GLP-1 in mice.
LX2761 delays intestinal glucose absorption in vivo to improve glycemic control.
M.Wt | 601.803 | |
Formula | C32H47N3O6S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Goodwin NC, et al. J Med Chem. 2017 Jan 26;60(2):710-721.
2. Powell DR, et al. J Pharmacol Exp Ther. 2017 Jul;362(1):85-97.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright